Home News

DORIA® presentation

The fast onset of action long-acting injectable of risperidone. Based on our ISM® patented technology.

Wed, 25/10/2017 - 13:50 0 min
Download related document
No votes yet
 
Related
Presentation of results for the first quarter of 2017
0 min
21/04/2017
The biosimilar Enoxaparin, a great opportunity for ROVI
“La historia de ROVI está unida a las heparinas desde nuestros inicios, por lo que este biosimilar de enoxaparina es una evolución lógica...
1 min
13/03/2017
Presentation on the biosimilar Enoxaparin of ROVI
0 min
13/03/2017